exactly right and if all the nay-sayers would actually take the time to read the SEC transcripts they would understand how well managed the cash flow of the company has been. The only time they family controlled investment businesses have sold stock is when the company needed cash (NOT the family) and fresh stock has been issued and held for typically 4 years.
The Whelans have not "made millions" but have managed the company to a stage where they have forced the FDA to create a new category since their product was truly bleeding edge no one has anything like it and got the clearance everyone said was impossible, unfortunately only for 2 conditions not general pain treatment which is why we are where we are today compared to where Andy thought we would be back in February with big Pharma having had their cards called decided they didn't want to play.
Market Data 
Markets 
AI
